[Form 4] Phibro Animal Health Corporation Insider Trading Activity
Phibro Animal Health Corporation (PAHC) reporting person Larry Lee Miller, Chief Operating Officer, was granted 5,184 restricted stock units (RSUs) on 08/15/2025. After the grant, Mr. Miller beneficially owns 35,184 shares of Class A Common Stock. The RSUs are contingent rights to receive one share per RSU and vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to his continued employment through each vesting date. The Form 4 was signed by an attorney-in-fact on 08/19/2025. The filing discloses a routine equity award to an executive with time-based vesting; no option exercises, sales, or derivative transactions are reported.
Phibro Animal Health Corporation (PAHC), soggetto segnalante Larry Lee Miller, Chief Operating Officer, ha ricevuto in data 08/15/2025 5.184 unit脿 azionarie vincolate (RSU). Dopo la concessione, il Sig. Miller detiene beneficiariamente 35.184 azioni di Class A Common Stock. Le RSU rappresentano diritti condizionati a ricevere una azione per ciascuna RSU e maturano in quote sostanzialmente uguali in ciascuno dei primi tre anniversari del 1掳 agosto 2025, subordinatamente al mantenimento del rapporto di lavoro fino a ciascuna data di maturazione. Il Modulo 4 猫 stato firmato da un procuratore il 08/19/2025. La comunicazione riferisce un premio azionario di routine a un dirigente con maturazione basata sul tempo; non sono riportate esercitazioni di opzioni, vendite o operazioni su strumenti derivati.
Phibro Animal Health Corporation (PAHC), la persona informante Larry Lee Miller, Director de Operaciones, recibi贸 el 15/08/2025 5.184 unidades de acciones restringidas (RSU). Tras la concesi贸n, el Sr. Miller posee beneficiariamente 35.184 acciones de Class A Common Stock. Las RSU son derechos condicionados a recibir una acci贸n por cada RSU y se consolidan en fracciones sustancialmente iguales en cada uno de los tres primeros aniversarios del 1 de agosto de 2025, sujetas a la continuidad en el empleo hasta cada fecha de consolidaci贸n. El Formulario 4 fue firmado por un apoderado el 19/08/2025. La presentaci贸n revela una asignaci贸n de acciones rutinaria a un directivo con adquisici贸n por tiempo; no se informan ejercicios de opciones, ventas ni operaciones con derivados.
Phibro Animal Health Corporation (PAHC)鞚� 瓿奠嫓鞛� Larry Lee Miller 斓滉碃鞖挫榿毂呾瀯鞛愲姅 2025-08-15鞐� 5,184臧滌潣 鞝滍暅攵�欤检嫕雼渼(RSU)毳� 攵�鞐皼鞎橃姷雼堧嫟. 攵�鞐� 頉� Miller 鞌姅 Class A 氤错喌欤� 35,184欤�毳� 鞁れ鞝侅溂搿� 氤挫湢頃橁矊 霅╇媹雼�. RSU電� 臧� RSU雼� 1欤茧ゼ 氚涭潉 靾� 鞛堧姅 臁瓣贝攵� 甓岆Μ鞚措┌, 2025雲� 8鞗� 1鞚�鞚� 鞁滌瀾鞙茧 頄ロ泟 3雲勳潣 臧� 旮半厫鞚检棎 瓯办潣 霃欖澕頃� 牍勳湪搿� 氩犾姢韺呺悩氅� 臧� 氩犾姢韺呾澕旯岇 瓿勳啀 攴茧頃挫暭 頃╇媹雼�. Form 4電� 2025-08-19鞐� 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟. 鞝滌稖靹滊姅 鞁滉皠 旮半皹 氩犾姢韺呾澊 鞝侅毄霅橂姅 瓴届榿歆勳棎 雽�頃� 鞝曣赴鞝� 欤检嫕 氤挫儊鞛勳潉 氚濏瀳氅�, 鞓奠厴 頄夓偓, 毵る弰 霕愲姅 韺岇儩靸來拡 瓯半灅電� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�.
Phibro Animal Health Corporation (PAHC), la personne d茅clarant Larry Lee Miller, Chief Operating Officer, s'est vu accorder le 15/08/2025 5 184 unit茅s d'actions restreintes (RSU). Apr猫s l'attribution, M. Miller d茅tient b茅n茅ficiairement 35 184 actions de Class A Common Stock. Les RSU sont des droits conditionnels 脿 recevoir une action par RSU et acqui猫rent des droits par fractions sensiblement 茅gales aux trois premiers anniversaires du 1er ao没t 2025, sous r茅serve de la poursuite de son emploi jusqu'脿 chaque date d'acquisition. Le formulaire 4 a 茅t茅 sign茅 par un mandataire le 19/08/2025. Le d茅p么t indique une attribution d'actions de routine 脿 un dirigeant avec acquisition bas茅e sur le temps ; aucun exercice d'option, vente ou op茅ration sur d茅riv茅s n'est signal茅.
Phibro Animal Health Corporation (PAHC), meldende Person Larry Lee Miller, Chief Operating Officer, erhielt am 15.08.2025 5.184 Restricted Stock Units (RSUs). Nach der Zuteilung besitzt Herr Miller wirtschaftlich 35.184 Aktien der Class A Common Stock. Die RSUs sind bedingte Anspr眉che auf eine Aktie je RSU und werden in im Wesentlichen gleichen Teilen an den ersten drei Jahrestagen des 1. August 2025 unverfallbar, vorbehaltlich seines fortgesetzten Arbeitsverh盲ltnisses bis zu den jeweiligen Vesting-Terminen. Das Formular 4 wurde am 19.08.2025 von einem Bevollm盲chtigten unterschrieben. Die Meldung offenbart eine routinem盲脽ige Aktienzuteilung an einen Manager mit zeitbasierter Vesting-Regelung; keine Aus眉bung von Optionen, Verk盲ufe oder derivative Transaktionen wurden berichtet.
- Time鈥慴ased RSU grant aligns executive interests with long鈥憈erm shareholder value
- No immediate sale reported, indicating retention rather than cashing out
- Vesting conditioned on continued employment, so value depends on tenure
- Potential future dilution when RSUs settle into Class A Common Stock
Insights
TL;DR: Executive received a time鈥慴ased RSU grant that vests over three years, aligning incentives with shareholder value.
The grant of 5,184 RSUs to the COO is a standard equity compensation tool intended to retain management and align interests with shareholders. Vesting is time鈥慴ased in equal installments across three anniversaries of August 1, 2025, which ties realized value to continued tenure rather than immediate liquidity. The increase to 35,184 beneficially owned shares is modest relative to typical executive holdings but meaningful for personal alignment. There are no sales or exercises reported, and no performance conditions disclosed, so the grant's realization depends solely on continued employment through vesting dates.
TL;DR: Routine insider award with employment鈥慶onditioned vesting; limited immediate market impact.
This Form 4 documents a non鈥慸erivative issuance of RSUs with zero immediate cash proceeds to the reporting person and no change in outstanding shares until settlement. Because the RSUs are restricted and vest over time, there is limited short鈥憈erm dilution and no material transactional risk disclosed. Investors should note that future share issuance upon vesting could create modest dilution, but the filing contains no evidence of performance鈥慴ased acceleration or transfer to third parties.
Phibro Animal Health Corporation (PAHC), soggetto segnalante Larry Lee Miller, Chief Operating Officer, ha ricevuto in data 08/15/2025 5.184 unit脿 azionarie vincolate (RSU). Dopo la concessione, il Sig. Miller detiene beneficiariamente 35.184 azioni di Class A Common Stock. Le RSU rappresentano diritti condizionati a ricevere una azione per ciascuna RSU e maturano in quote sostanzialmente uguali in ciascuno dei primi tre anniversari del 1掳 agosto 2025, subordinatamente al mantenimento del rapporto di lavoro fino a ciascuna data di maturazione. Il Modulo 4 猫 stato firmato da un procuratore il 08/19/2025. La comunicazione riferisce un premio azionario di routine a un dirigente con maturazione basata sul tempo; non sono riportate esercitazioni di opzioni, vendite o operazioni su strumenti derivati.
Phibro Animal Health Corporation (PAHC), la persona informante Larry Lee Miller, Director de Operaciones, recibi贸 el 15/08/2025 5.184 unidades de acciones restringidas (RSU). Tras la concesi贸n, el Sr. Miller posee beneficiariamente 35.184 acciones de Class A Common Stock. Las RSU son derechos condicionados a recibir una acci贸n por cada RSU y se consolidan en fracciones sustancialmente iguales en cada uno de los tres primeros aniversarios del 1 de agosto de 2025, sujetas a la continuidad en el empleo hasta cada fecha de consolidaci贸n. El Formulario 4 fue firmado por un apoderado el 19/08/2025. La presentaci贸n revela una asignaci贸n de acciones rutinaria a un directivo con adquisici贸n por tiempo; no se informan ejercicios de opciones, ventas ni operaciones con derivados.
Phibro Animal Health Corporation (PAHC)鞚� 瓿奠嫓鞛� Larry Lee Miller 斓滉碃鞖挫榿毂呾瀯鞛愲姅 2025-08-15鞐� 5,184臧滌潣 鞝滍暅攵�欤检嫕雼渼(RSU)毳� 攵�鞐皼鞎橃姷雼堧嫟. 攵�鞐� 頉� Miller 鞌姅 Class A 氤错喌欤� 35,184欤�毳� 鞁れ鞝侅溂搿� 氤挫湢頃橁矊 霅╇媹雼�. RSU電� 臧� RSU雼� 1欤茧ゼ 氚涭潉 靾� 鞛堧姅 臁瓣贝攵� 甓岆Μ鞚措┌, 2025雲� 8鞗� 1鞚�鞚� 鞁滌瀾鞙茧 頄ロ泟 3雲勳潣 臧� 旮半厫鞚检棎 瓯办潣 霃欖澕頃� 牍勳湪搿� 氩犾姢韺呺悩氅� 臧� 氩犾姢韺呾澕旯岇 瓿勳啀 攴茧頃挫暭 頃╇媹雼�. Form 4電� 2025-08-19鞐� 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟. 鞝滌稖靹滊姅 鞁滉皠 旮半皹 氩犾姢韺呾澊 鞝侅毄霅橂姅 瓴届榿歆勳棎 雽�頃� 鞝曣赴鞝� 欤检嫕 氤挫儊鞛勳潉 氚濏瀳氅�, 鞓奠厴 頄夓偓, 毵る弰 霕愲姅 韺岇儩靸來拡 瓯半灅電� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�.
Phibro Animal Health Corporation (PAHC), la personne d茅clarant Larry Lee Miller, Chief Operating Officer, s'est vu accorder le 15/08/2025 5 184 unit茅s d'actions restreintes (RSU). Apr猫s l'attribution, M. Miller d茅tient b茅n茅ficiairement 35 184 actions de Class A Common Stock. Les RSU sont des droits conditionnels 脿 recevoir une action par RSU et acqui猫rent des droits par fractions sensiblement 茅gales aux trois premiers anniversaires du 1er ao没t 2025, sous r茅serve de la poursuite de son emploi jusqu'脿 chaque date d'acquisition. Le formulaire 4 a 茅t茅 sign茅 par un mandataire le 19/08/2025. Le d茅p么t indique une attribution d'actions de routine 脿 un dirigeant avec acquisition bas茅e sur le temps ; aucun exercice d'option, vente ou op茅ration sur d茅riv茅s n'est signal茅.
Phibro Animal Health Corporation (PAHC), meldende Person Larry Lee Miller, Chief Operating Officer, erhielt am 15.08.2025 5.184 Restricted Stock Units (RSUs). Nach der Zuteilung besitzt Herr Miller wirtschaftlich 35.184 Aktien der Class A Common Stock. Die RSUs sind bedingte Anspr眉che auf eine Aktie je RSU und werden in im Wesentlichen gleichen Teilen an den ersten drei Jahrestagen des 1. August 2025 unverfallbar, vorbehaltlich seines fortgesetzten Arbeitsverh盲ltnisses bis zu den jeweiligen Vesting-Terminen. Das Formular 4 wurde am 19.08.2025 von einem Bevollm盲chtigten unterschrieben. Die Meldung offenbart eine routinem盲脽ige Aktienzuteilung an einen Manager mit zeitbasierter Vesting-Regelung; keine Aus眉bung von Optionen, Verk盲ufe oder derivative Transaktionen wurden berichtet.
FAQ
What did PAHC insider Larry Lee Miller acquire on 08/15/2025?
How many shares does Larry Lee Miller beneficially own after the reported transaction?
When do the RSUs vest for Larry Lee Miller?
Was there any cash paid for the RSUs by the reporting person?
Who signed the Form 4 filing for Larry Lee Miller?
